NCT05924893View on ClinicalTrials.gov

The Use of Naltrexone Hydrochloride to Promote Healing in Patients With Resistant Non-infectious Corneal Ulcer

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

June 1, 2022

Study Completion Date

December 15, 2022

Conditions

Cornea Ulcer

Interventions

DRUG

Naltrexone Hydrochloride

naltrexone film

DRUG

Carboxy methyl cellulose

Carboxy methyl cellulose drops

Trial Locations (1)

Unknown

Faculty of Medicine, Minya

All Listed Sponsors

lead

Minia University

OTHER

NCT05924893 - The Use of Naltrexone Hydrochloride to Promote Healing in Patients With Resistant Non-infectious Corneal Ulcer | Biotech Hunter | Biotech Hunter